Search Results - "Ayora, Pilar"
-
1
A reproducible and safe at-home allogeneic haematopoietic cell transplant program: first experience in Central and Southern Europe
Published in Bone marrow transplantation (Basingstoke) (01-05-2020)“…In 2015, we implemented an at-home allogeneic haematopoietic cell transplant (allo-HCT) program. Between 2015 and 2018, 252 patients underwent allo-HCT; 41…”
Get full text
Journal Article -
2
P1391: VARNIMCABTAGENE AUTOLEUCEL (VAR‐CEL) IN RELAPSED/ REFRACTORY CD19+ NON‐HODGKIN LYMPHOMA
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
3
P1394: RITUXIMAB BASED LYMPHODEPLETION MAY INCREASE ENGRAFTMENT AND EFFICACY OF SECOND INFUSIONS OF CART19 CELLS IN B‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
4
Impact of Salvage and Bridging Therapy in Adult Patients with Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL) Referred for Anti-CD19 CAR T-Cell Therapy: An Intention to Treat Analysis
Published in Blood (02-11-2023)“…Background: Prognosis of relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (ALL) is poor, particularly after allogeneic hematopoietic cell…”
Get full text
Journal Article -
5
Varnimcabtagene Autoleucel (ARI-0001) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Richter Transformation (RT)
Published in Blood (02-11-2023)“…Background: The prognosis of CLL patients that do not respond to targeted therapy is unfavourable, especially in the case of adverse genomic aberrations (e.g…”
Get full text
Journal Article -
6
The academic point-of-care anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel (ARI-0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma
Published in British journal of haematology (01-02-2024)“…Varnimcabtagene autoleucel (var-cel) is an academic anti-CD19 chimeric antigen receptor (CAR) product used for the treatment of non-Hodgkin lymphoma (NHL) in…”
Get full text
Journal Article -
7
Nursing care for chimeric antigen receptor T cell therapy survivors: A literature review
Published in Asia-Pacific journal of oncology nursing (01-06-2024)“…Chimeric antigen receptor T cell (CAR-T) therapy is an immunotherapy that involves genetically modifying the patient's own T cells to express a chimeric…”
Get full text
Journal Article -
8
At-Home Management of Adult Patients Following Consolidation Chemotherapy for Acute Myeloid Leukemia
Published in Blood (06-12-2014)“…Background: Consolidation chemotherapy for adult patients with acute myeloid leukemia (AML) who have achieved a complete response after induction treatment is…”
Get full text
Journal Article -
9
At-home Management of Adult Patients Following Consolidation Chemotherapy for Acute Myeloid Leukemia
Published in Clinical lymphoma, myeloma and leukemia (01-09-2015)Get full text
Journal Article